These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36455864)

  • 21. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.
    Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Ozawa Y; Maezawa Y; Kano K; Murakawa M; Kazama K; Segami K; Hara K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
    In Vivo; 2020; 34(5):2783-2790. PubMed ID: 32871815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors.
    Takada Y; Kawashima H; Ohno E; Ishikawa T; Mizutani Y; Iida T; Yamamura T; Kakushima N; Furukawa K; Nakamura M; Honda T; Ishigami M; Ito A; Hirooka Y
    J Gastroenterol; 2022 Mar; 57(3):199-207. PubMed ID: 35098349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma.
    Traweek RS; Lyu HG; Witt RG; Snyder RA; Nassif EF; Krijgh DD; Smith JM; Tilney GS; Feng C; Chiang YJ; Torres KE; Roubaud MJ; Scally CP; Hunt KK; Keung EZ; Mericli AF; Roland CL
    Ann Surg Oncol; 2024 Jun; 31(6):4138-4147. PubMed ID: 38396039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidity indexing for prediction of the clinical outcome after stereotactic body radiation therapy in non-small cell lung cancer.
    Dreyer J; Bremer M; Henkenberens C
    Radiat Oncol; 2018 Nov; 13(1):213. PubMed ID: 30390700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age-adjusted Charlson comorbidity index in recurrent glioblastoma: a new prognostic factor?
    Barz M; Bette S; Janssen I; Aftahy AK; Huber T; Liesche-Starnecker F; Ryang YM; Wiestler B; Combs SE; Meyer B; Gempt J
    BMC Neurol; 2022 Jan; 22(1):32. PubMed ID: 35062885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic significance of margin width for extremity and trunk sarcoma.
    McKee MD; Liu DF; Brooks JJ; Gibbs JF; Driscoll DL; Kraybill WG
    J Surg Oncol; 2004 Feb; 85(2):68-76. PubMed ID: 14755506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer.
    Suidan RS; Leitao MM; Zivanovic O; Gardner GJ; Long Roche KC; Sonoda Y; Levine DA; Jewell EL; Brown CL; Abu-Rustum NR; Charlson ME; Chi DS
    Gynecol Oncol; 2015 Aug; 138(2):246-51. PubMed ID: 26037900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
    Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A
    Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.
    Ethun CG; Lopez-Aguiar AG; Switchenko JM; Gillespie TW; Delman KA; Staley CA; Maithel SK; Cardona K
    Ann Surg Oncol; 2019 Dec; 26(13):4723-4729. PubMed ID: 31502023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors for local recurrence and mortality in adult soft tissue sarcoma of the extremities and trunk wall: a cohort study of 922 consecutive patients.
    Maretty-Nielsen K; Aggerholm-Pedersen N; Safwat A; Jørgensen PH; Hansen BH; Baerentzen S; Pedersen AB; Keller J
    Acta Orthop; 2014 Jun; 85(3):323-32. PubMed ID: 24694277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables.
    Stojadinovic A; Leung DH; Allen P; Lewis JJ; Jaques DP; Brennan MF
    J Clin Oncol; 2002 Nov; 20(21):4344-52. PubMed ID: 12409334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in soft tissue sarcoma.
    Maretty-Nielsen K
    Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of patients with soft tissue sarcomas of the extremities and trunk treated by (neo)adjuvant intensity modulated radiation therapy with curative intent.
    Dapper H; Diehl C; Knebel C; Mogler C; Borm K; Dobiasch S; Combs SE; Peeken JC
    Radiat Oncol; 2023 Mar; 18(1):44. PubMed ID: 36869396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
    Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
    Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comorbidity is independently associated with poor outcome in extremity soft tissue sarcoma.
    Kang S; Kim HS; Kim W; Kim JH; Kang SH; Han I
    Clin Orthop Surg; 2015 Mar; 7(1):120-30. PubMed ID: 25729528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a model based on the age-adjusted Charlson comorbidity index to predict survival for resected perihilar cholangiocarcinoma.
    Pan Y; Liu ZP; Dai HS; Chen WY; Luo Y; Wang YZ; Gao SY; Wang ZR; Dong JL; Liu YH; Yin XY; Liu XC; Fan HN; Bai J; Jiang Y; Cheng JJ; Zhang YQ; Chen ZY
    World J Gastrointest Oncol; 2023 Jun; 15(6):1036-1050. PubMed ID: 37389112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of comorbidities in patients with carcinoma of the major salivary glands.
    Becker C; Dahlem KKK; Pfeiffer J
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1651-1657. PubMed ID: 27888340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival in primary soft tissue sarcoma of the extremities and trunk.
    Peiper M; Zurakowski D; Zornig C
    Langenbecks Arch Chir; 1997; 382(4):203-8. PubMed ID: 9396000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
    Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
    Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.
    Takemura K; Takenaka Y; Ashida N; Shimizu K; Oya R; Kitamura T; Yamamoto Y; Uno A
    Acta Otolaryngol; 2017 Dec; 137(12):1307-1312. PubMed ID: 28875745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.